Jamieson Sheffield is an accomplished strategic consultant and healthcare expert with a focus on personalized medicine and patient access. With a strong track record of building and leading successful teams, Sheffield has held key leadership positions in market analysis and strategy at both Vir Biotechnology and Genentech, where he served as Group Manager and Cross Portfolio Lead, respectively. Before transitioning to consulting, Sheffield earned a degree in Molecular Biology from the University of California, San Diego, and an MBA from the University of Pennsylvania's Wharton School. He has worked in a variety of capacities across the healthcare industry, from sample bank supervision to biomarker discovery, and remains a prominent voice on topics ranging from healthcare policy to customer engagement and personalized healthcare strategy.